PAPER Cao H, Han X, Jia Y, Zhang B

Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.

Aging (Albany NY). 2021 Apr 4;13(8):11455-11469. PubMed: 33839699

PAPER Peterson Hiller A

Response to the retraction of papers by Yoshihiro Sato- a review of vitamin D and Parkinson's disease.

Maturitas. 2021 Jun;148:54. Epub 2021 Mar 24 PubMed: 33838971

PAPER Milanowski ŁM, Lindemann JA, Hoffman-Zacharska D, Soto-Beasley AI, Barcikowska M, Boczarska-Jedynak M, Deutschlander A, Kłodowska G, Dulski J, Fedoryshyn L, Friedman A, Jamrozik Z, Janik P, Karpinsky K, Koziorowski D, Krygowska-Wajs A, Jasińska-Myga B, Opala G, Potulska-Chromik A, Pulyk A, Rektorova I, Sanotsky Y, Siuda J, Sławek J, Śmiłowska K, Szczechowski L, Rudzińska-Bar M, Walton RL, Ross OA, Wszolek ZK

Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe.

Parkinsonism Relat Disord. 2021 May;86:48-51. Epub 2021 Apr 2 PubMed: 33845304

PAPER Labandeira CM, Fraga-Bau A, Arias Ron D, Muñoz A, Alonso-Losada G, Koukoulis A, Romero-Lopez J, Rodriguez-Perez AI

Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.

Front Neuroendocrinol. 2021 Jul;62:100914. Epub 2021 Apr 15 PubMed: 33845041

PAPER Stefani A, Högl B

A step forward in understanding the role of sleep and its link to neurodegeneration.

Brain. 2021 Apr 12;144(3):700-702. PubMed: 33844834

PAPER Mole J, Mead S, Rudge P, Nihat A, Mok T, Collinge J, Caine D

Cognitive decline heralds onset of symptomatic inherited prion disease.

Brain. 2021 Apr 12;144(3):989-998. PubMed: 33844831

PAPER Steele TA, St Louis EK, Videnovic A, Auger RR

Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease.

Neurotherapeutics. 2021 Jan;18(1):53-74. Epub 2021 Apr 12 PubMed: 33844152

PAPER Niu Y, Zhang J, Dong M

Nrf2 as a potential target for Parkinson's disease therapy.

J Mol Med (Berl). 2021 Jul;99(7):917-931. Epub 2021 Apr 12 PubMed: 33844027

PAPER Zhang JV, Irwin DJ, Blennow K, Zetterberg H, Lee EB, Shaw LM, Rascovsky K, Massimo L, McMillan CT, Chen-Plotkin A, Elman L, Lee VM, McCluskey L, Toledo JB, Weintraub D, Wolk D, Trojanowski JQ, Grossman M

Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration.

Neurol Clin Pract. 2021 Apr;11(2):105-116. PubMed: 33842063

PAPER Sen MK, Hossain MJ

Oligodendrocyte-Specific Mechanisms of Myelin Thinning: Implications for Neurodegenerative Diseases.

Front Neurosci. 2021;15:663053. Epub 2021 Mar 24 PubMed: 33841096

PAPER Varlow C, Mossine AV, Bernard-Gauthier V, Scott PJ, Vasdev N

Radiofluorination of oxazole-carboxamides for preclinical PET neuroimaging of GSK-3.

J Fluor Chem. 2021 May;245 Epub 2021 Feb 21 PubMed: 33840834

PAPER Khoury R, Liu Y, Sheheryar Q, Grossberg GT

Pharmacotherapy for Frontotemporal Dementia.

CNS Drugs. 2021 Apr;35(4):425-438. Epub 2021 Apr 11 PubMed: 33840052

PAPER Shao H, Li X, Hayashi S, Bertron JL, Schwarz DM, Tang BC, Gestwicki JE

Inhibitors of heat shock protein 70 (Hsp70) with enhanced metabolic stability reduce tau levels.

Bioorg Med Chem Lett. 2021 Jun 1;41:128025. Epub 2021 Apr 9 PubMed: 33839251

PAPER Velayudhan L, McGoohan KL, Bhattacharyya S

Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis.

JAMA Netw Open. 2021 Feb 1;4(2):e2035913. PubMed: 33528550

PAPER Jang BG, Lee J, Choi B, Koh YH, Kim MJ

Unexpected beta-amyloid production by middle doses of resveratrol through stabilization of APP protein and AMPK-mediated inhibition of trypsin-like proteasome activity in a cell model of Alzheimer's disease.

Food Chem Toxicol. 2021 Jun;152:112185. Epub 2021 Apr 14 PubMed: 33845068